Skip to content

Drug interactions

Bosentan + Brigatinib

Severity: Moderate

Bosentan and Brigatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan is a moderate CYP3A4 inducer and can lower brigatinib exposure. Reduced brigatinib levels may compromise control of ALK-positive lung cancer.

What this interaction means in plain words

Bosentan and Brigatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Brigatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 by bosentan increases brigatinib metabolism.

What to do

Prefer an alternative to bosentan where possible. If coadministration is unavoidable, monitor tumour response closely; labeling for moderate inducers suggests considering brigatinib dose increases only under specialist guidance.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Brigatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Brigatinib?

MediHelp rates the interaction as moderate. Bosentan and Brigatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosentan is a moderate CYP3A4 inducer and can lower brigatinib exposure. Reduced brigatinib levels may compromise control of ALK-positive lung cancer.

How serious is the interaction between Bosentan and Brigatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an alternative to bosentan where possible. If coadministration is unavoidable, monitor tumour response closely; labeling for moderate inducers suggests considering brigatinib dose increases only under specialist guidance.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in